Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00063817 · ClinicalTrials.gov registry record · Phase 1
Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow Transplant
A Phase 1 study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- Phase 1
- Development phase
- 5
- Enrollment target
NCT00063817 is a Phase 1 study that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 5 participants.
The verdict
NCT00063817, a Phase 1 study, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
This study will examine the safety and effectiveness of a combination kidney and bone marrow transplant from a relative with the same (or nearly the same) blood cell type as the transplant recipient. An investigational medication will be given prior to and after the transplant to help protect the transplanted kidney from attack by the body's immune system.
Interventions
- DRUG Conditioning Regimen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2003-06 |
| Est. Completion | 2009-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00063817
The ClinicalTrials.gov registry entry for NCT00063817 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Conditioning Regimen is the first listed.
NCT00063817 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00063817 about?
NCT00063817 is a clinical study titled "Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow Transplant". This study will examine the safety and effectiveness of a combination kidney and bone marrow transplant from a relative with the same (or nearly the same) blood cell type as the transplant recipient. An investigational medication will be given prior to and after the transplant to help protect the tr...
What is the current status of trial NCT00063817?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 5 participants. The study started on 2003-06. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00063817?
The interventions under investigation include: Conditioning Regimen (DRUG).
Who is sponsoring clinical trial NCT00063817?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.